Literature DB >> 29555594

Ultrastructural Alteration of Pulmonary Capillary Endothelial Glycocalyx During Endotoxemia.

Risa Inagawa1, Hideshi Okada2, Genzou Takemura3, Kodai Suzuki1, Chihiro Takada1, Hirohisa Yano1, Yoshiaki Ando1, Takahiro Usui1, Yasuaki Hotta4, Nagisa Miyazaki3, Akiko Tsujimoto3, Ryogen Zaikokuji5, Atsumu Matsumoto1, Tomonori Kawaguchi1, Tomoaki Doi1, Takahiro Yoshida1, Shozo Yoshida1, Keisuke Kumada1, Hiroaki Ushikoshi1, Izumi Toyoda1, Shinji Ogura1.   

Abstract

BACKGROUND: The most recent diagnostic criteria for sepsis include organ failure. Microvascular endothelial injury is believed to lead to the multiple organ failure seen in sepsis, although the precise mechanism is still controversial. ARDS is the primary complication during the sequential development of multiple organ dysfunction in sepsis, and endothelial injury is deeply involved. Sugar-protein glycocalyx coats all healthy vascular endothelium, and its disruption is one factor believed to contribute to microvascular endothelial dysfunction during sepsis. The goal of this study was to observe the three-dimensional ultrastructural alterations in the pulmonary capillary endothelium, including the glycocalyx, during sepsis-induced pulmonary vasculitis.
METHODS: This study investigated the three-dimensional ultrastructure of pulmonary vascular endothelial glycocalyx in a mouse lipopolysaccharide-induced endotoxemia model. Lungs were fixed with lanthanum-containing alkaline fixative to preserve the glycocalyx.
RESULTS: On both scanning and transmission electron microscopic imaging, the capillary endothelial glycocalyx appeared as a moss-like structure entirely covering the endothelial cell surface in normal mice. In the septic lung following liposaccharide injection, however, this structure was severely disrupted; it appeared to be peeling away and coagulated. In addition, syndecan-1 levels were significantly reduced in the septic lung, and numerous spherical structures containing glycocalyx were observed on the endothelial surface.
CONCLUSIONS: It appears that endothelial glycocalyx in the lung is markedly disrupted under experimental endotoxemia conditions. This finding supports the notion that disruption of the glycocalyx is causally related to the microvascular endothelial dysfunction that is characteristic of sepsis-induced ARDS.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute lung injury; pathology; sepsis; vasculitis

Mesh:

Substances:

Year:  2018        PMID: 29555594     DOI: 10.1016/j.chest.2018.03.003

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

Review 1.  The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury.

Authors:  Johan Rebetz; John W Semple; Rick Kapur
Journal:  Transfus Med Hemother       Date:  2018-09-21       Impact factor: 3.747

Review 2.  Glycocalyx in Endotoxemia and Sepsis.

Authors:  Michael S Goligorsky; Dong Sun
Journal:  Am J Pathol       Date:  2020-02-06       Impact factor: 4.307

3.  Fraxin Alleviates LPS-Induced ARDS by Downregulating Inflammatory Responses and Oxidative Damages and Reducing Pulmonary Vascular Permeability.

Authors:  Xiaohong Ma; Xiangyong Liu; Jiali Feng; Dong Zhang; Lina Huang; Dongxiao Li; Liang Yin; Lan Li; Xiao-Zhi Wang
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

4.  Glycocalyx Disruption Triggers Human Monocyte Activation in Acute Heart Failure Syndromes.

Authors:  Olga G Grushko; Steven Cho; Ashley M Tate; Robert S Rosenson; David J Pinsky; Jacob M Haus; Scott L Hummel; Sascha N Goonewardena
Journal:  Cardiovasc Drugs Ther       Date:  2022-10-19       Impact factor: 3.947

5.  Neutrophil Elastase Inhibition Ameliorates Endotoxin-induced Myocardial Injury Accompanying Degradation of Cardiac Capillary Glycocalyx.

Authors:  Tetsuya Fukuta; Hideshi Okada; Genzou Takemura; Kodai Suzuki; Chihiro Takada; Hiroyuki Tomita; Akio Suzuki; Kazumasa Oda; Akihiro Uchida; Saori Matsuo; Hirotsugu Fukuda; Hirohisa Yano; Isamu Muraki; Ryogen Zaikokuji; Ayumi Kuroda; Ayane Nishio; So Sampei; Nagisa Miyazaki; Yasuaki Hotta; Noriaki Yamada; Takatomo Watanabe; Kentaro Morishita; Tomoaki Doi; Takahiro Yoshida; Hiroaki Ushikoshi; Shozo Yoshida; Yoichi Maekawa; Shinji Ogura
Journal:  Shock       Date:  2020-09       Impact factor: 3.533

Review 6.  Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.

Authors:  Melvin R Hayden
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

7.  Extracellular Vesicles From Adipose Tissue-Derived Stem Cells Affect Notch-miR148a-3p Axis to Regulate Polarization of Macrophages and Alleviate Sepsis in Mice.

Authors:  Xiaozhi Bai; Junjie Li; Lincheng Li; Mingchuan Liu; Yang Liu; Mengyuan Cao; Ke Tao; Songtao Xie; Dahai Hu
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

8.  Thrombin-cleaved syndecan-3/-4 ectodomain fragments mediate endothelial barrier dysfunction.

Authors:  Melanie Jannaway; Xiaoyuan Yang; Jamie E Meegan; Danielle C Coleman; Sarah Y Yuan
Journal:  PLoS One       Date:  2019-05-15       Impact factor: 3.240

9.  Brain-Specific Ultrastructure of Capillary Endothelial Glycocalyx and Its Possible Contribution for Blood Brain Barrier.

Authors:  Yoshiaki Ando; Hideshi Okada; Genzou Takemura; Kodai Suzuki; Chihiro Takada; Hiroyuki Tomita; Ryogen Zaikokuji; Yasuaki Hotta; Nagisa Miyazaki; Hirohisa Yano; Isamu Muraki; Ayumi Kuroda; Hirotsugu Fukuda; Yuki Kawasaki; Haruka Okamoto; Tomonori Kawaguchi; Takatomo Watanabe; Tomoaki Doi; Takahiro Yoshida; Hiroaki Ushikoshi; Shozo Yoshida; Shinji Ogura
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

10.  Three-dimensional electron microscopy for endothelial glycocalyx observation using Alcian blue with silver enhancement.

Authors:  Shumpei Mukai; Takashi Takaki; Tasuku Nagumo; Mariko Sano; Dedong Kang; Masafumi Takimoto; Kazuho Honda
Journal:  Med Mol Morphol       Date:  2020-10-06       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.